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Abstract
We previously reported a multigene family of monodomain Kunitz proteins from Echinococ-
cus granulosus (EgKU-1-EgKU-8), and provided evidence that some EgKUs are secreted
by larval worms to the host interface. In addition, functional studies and homology modeling
suggested that, similar to monodomain Kunitz families present in animal venoms, the E.
granulosus family could include peptidase inhibitors as well as channel blockers. Using
enzyme kinetics and whole-cell patch-clamp, we now demonstrate that the EgKUs are
indeed functionally diverse. In fact, most of them behaved as high affinity inhibitors of either
chymotrypsin (EgKU-2-EgKU-3) or trypsin (EgKU-5-EgKU-8). In contrast, the close para-
logs EgKU-1 and EgKU-4 blocked voltage-dependent potassium channels (Kv); and also
pH-dependent sodium channels (ASICs), while showing null (EgKU-1) or marginal (EgKU-
4) peptidase inhibitory activity. We also confirmed the presence of EgKUs in secretions
from other parasite stages, notably from adult worms and metacestodes. Interestingly, data
from genome projects reveal that at least eight additional monodomain Kunitz proteins are
encoded in the genome; that particular EgKUs are up-regulated in various stages; and that
analogous Kunitz families exist in other medically important cestodes, but not in trematodes.
Members of this expanded family of secreted cestode proteins thus have the potential to
block, through high affinity interactions, the function of host counterparts (either peptidases
or cation channels) and contribute to the establishment and persistence of infection. From a
more general perspective, our results confirm that multigene families of Kunitz inhibitors
from parasite secretions and animal venoms display a similar functional diversity and thus,
that host-parasite co-evolution may also drive the emergence of a new function associated
with the Kunitz scaffold.
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Author summary
Parasite secretions are key players at host-parasite interfaces: parasite establishment and
persistence rely, to a great extent, on interactions between these molecules and their host
counterparts. We present the functional characterization of a multigene family of secreted
Kunitz proteins from the cestode Echinococcus granulosus. Kunitz proteins are a class of
metazoan high affinity serine peptidase inhibitors. In addition, families of Kunitz proteins
are frequent components of animal venoms; besides inhibiting peptidases, some of these
“Kunitz toxins” block cation channels and thus, provide a remarkable example of protein
evolution where natural selection has driven the emergence of a new function associated
with the same molecular scaffold. Using enzyme kinetics and electrophysiological assays,
we demonstrated that the E. granulosus Kunitz family includes peptidase inhibitors as well
as channel blockers. This diversity highlights an interesting similarity between animal tox-
ins and parasite secretions that had not been previously described. Furthermore, the pres-
ence of analogous families of Kunitz proteins appears to be a distinctive trait of cestode
genomes. We thus propose that these molecules contribute to a successful infection acting
at the parasite-host interface. In addition, because they bear a strong specificity towards
their targets, they are uniquely suited for the development of pharmaceuticals.
Introduction
Cestodes are a neglected group of platyhelminth parasites, despite causing chronic infections
to humans and domestic animals worldwide [1]. Together with other researchers around the
world [2], we have been using Echinococcus granulosus as a model to study the molecular basis
of the host-parasite cross-talk during cestode infections [3,4,5]. E. granulosus is the agent of
cystic echinococcosis, a medically and economically important worldwide zoonosis, with en-
demic foci in Central Asia, China, South America and Africa [6]. Like all taeniid cestodes, it
has a life cycle involving two mammals: a non carnivore intermediate host (harboring the
larva) and a carnivore definitive host (harboring the hermaphroditic adult). Intermediate
hosts (ungulates such as sheep, cattle and pigs; and, accidentally, also humans) become in-
fected by ingestion of eggs containing oncospheres that develop at visceral sites into bladder-
like metacestodes (hydatid cysts). These latter are bounded by a wall whose inner germinal
layer gives rise to larval worms (protoscoleces) by asexual budding; protoscoleces are bathed in
hydatid fluid that includes host plasmatic proteins and parasite secretions. Infection in the
definitive host (always a canid, most often dogs) arises from ingestion of protoscoleces that,
upon activation by contact with stomach acid, enzymes and bile acids, evaginate and attach to
the mucosa of the duodenum, where they develop into adult tapeworms that can reside in the
gut for long periods without causing any apparent damage [7]. Specific anatomical structures
allow such a close contact at the canid-worm interface that E. granulosus has been regarded as
both a tissue and a luminal parasite [8]. The molecular mechanisms underlying its successful
establishment and persistence in the hostile environment of the dog duodenum are unknown.
With the aim of identifying molecules participating in the E. granulosus–dog cross-talk, we
surveyed the genes expressed by protoscoleces and pepsin/H+-treated protoscoleces. We thus
identified a multigene family of Kunitz-type inhibitors (EgKUs). These molecules were associ-
ated mostly with treated protoscoleces, suggesting that they play roles at the initial phases of
infection [3]. Kunitz inhibitors are a class of metazoan serine peptidase inhibitors, whose pro-
totype is the bovine pancreatic inhibitor of trypsin (BPTI; family I2 of the MEROPS database;
http://merops.sanger.ac.uk/) [9]. They are competitive inhibitors acting in a substrate-like
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manner, that form very stable complexes of 1:1 stoichiometry with their target enzymes,
devoid of activity. The interaction between the enzyme and the inhibitor is highly dependent
on the residue located at the position P1 of the antipeptidase loop (position 15 of mature
BPTI) [10]. In addition, families of Kunitz inhibitors are frequent components of the saliva
and secretions from hematophagous animals and also of animal venoms. These “Kunitz-type
toxins” have been described in the venoms from snakes [11], sea anemones [12,13], cone snails
[14], spiders [15], scorpions [16,17] as well as in the saliva of blood-sucking arthropods [18,19]
and in the secretions of hematophagous nematodes [20]. Interestingly, besides inhibiting pep-
tidases, some Kunitz toxins, until now described only in animal venoms, block various types of
cation channels. Furthermore, some act solely as channel blockers. A set of neurotoxins pres-
ent in the venoms of mamba snakes (‘‘dendrotoxins”), whose function is to paralyze the prey,
is the best known example [21].
We previously reported the molecular features of eight EgKUs (that we named EgKU-1-
EgKU-8) and provided evidence that some of them (notably, EgKU-3 and EgKU-8) are secreted
by protoscoleces. Although diverse, these EgKUs were found to group into three pairs of close
paralogs (EgKU-1/EgKU-4; EgKU-3/EgKU-8; EgKU-6/EgKU-7), which would be the products
of recent gene duplications. In addition, we carried out detailed kinetic studies with native
EgKU-1 and EgKU-8 purified from protoscoleces that revealed their possible functionalities.
EgKU-8 behaved as a slow, tight-binding inhibitor of trypsins, with global inhibition constants
(KI

) in the 10−11 M range, and interacted with enzymes through a mechanism involving two
reversible steps; an initial relatively fast formation of an enzyme-inhibitor complex followed by
a slow transition to a tight complex. In sharp contrast, EgKU-1 did not inhibit any of the assayed
peptidases. Interestingly, molecular modeling revealed that structural elements associated with
activity in Kunitz cation-channel blockers are also present in EgKU-1. Indeed, α-dendrotoxin
(α-DTX), a well characterized blocker of specific voltage-activated K+-channels (Kv) [21], was—
at the time—the best overall template of EgKU-1; and several amino acids important for toxin
activity were found to be conserved in the consensus model of the parasite molecule, supporting
the notion that it is a putative cation channel blocker. Presumed orthologs of the EgKUs (pepti-
dase inhibitors as well as channel blockers) were also found to be present in the transcriptomes
from the other medically important cestodes (notably, E. multilocularis and Taenia solium, the
agents of alveolar echinococcosis and cysticercosis, respectively), indicating that families of
monodomain Kunitz inhibitors are also present in closely related organisms [3].
In this article, we characterize the activity of EgKU-1–EgKU-8 using enzyme kinetics and
whole-cell patch clamp assays. We thus demonstrate that the E. granulosus Kunitz family is
indeed functionally diverse. On the one hand, we show that all but EgKU-1 and EgKU-4 behave
as high affinity inhibitors of either chymotrypsin or trypsin. On the other hand, patch-clamp
assays on rat dorsal root ganglion (DRG) neurons confirmed that EgKU-1, and also its close
paralog EgKU-4, block Kv. Furthermore, the two proteins also block pH-dependent sodium
channels (acid sensing ion channels, ASICs), a previously unreported activity for Kunitz inhibi-
tors, that we recently described for α-DTX [22]. In addition, we provide further evidence of the
presence of EgKUs in parasite secretions. We discuss the significance of these results taking into
account available genomic and transcriptomic data from E. granulosus and related cestodes.
Results
Except for EgKU-1 and EgKU-4, the EgKUs are high affinity inhibitors of
serine peptidases
In our previous study, working with native EgKU-1 and EgKU-8, we demonstrated that EgKU-
8 is a high affinity inhibitor of trypsins, whereas EgKU-1 did not inhibit any of the assayed
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peptidases [3]. To further advance in the functional characterization of the family, we prepared
recombinants of the eight EgKUs. We carried out a preliminary screening of the serine pepti-
dase inhibition activity of recombinant EgKU-2–EgKU-7. Of note, in the case of EgKU-8 both
the native inhibitor and the recombinant protein behaved similarly (KI

60 ± 13 versus 50 ± 10
pM, for native and recombinant EgKU-8, respectively). Using pancreatic enzymes, we ana-
lyzed whether the EgKUs showed the inhibition profiles that may be predicted from the respec-
tive amino acid at position P1: EgKU-2 (Trp in P1) and EgKU-3 (Leu in P1) are candidate
chymotrypsin inhibitors, whereas EgKU-4-EgKU-7 (Arg in P1) are predicted to inhibit trypsin.
All six EgKUs showed the expected activities. We subsequently performed titration assays to
analyze whether they behaved as high affinity inhibitors. These studies indicated that, except
for EgKU-4, the close paralog of EgKU-1, the EgKUs are high affinity inhibitors of bovine chy-
motrypsin (EgKU-2 and EgKU-3) or trypsin (EgKU-5-EgKU-8) (Table 1 and Fig 1). In view of
these results, we further characterized the inhibitory activity of EgKU-3, the closest paralog of
EgKU-8.
EgKU-3 inhibits chymotrypsin with high affinity through a two-step
mechanism
We carried out kinetic studies using bovine chymotrypsin A and also chymotrypsin purified
from dog pancreas, i. e. chymotrypsin B (chymotrypsin A is absent from dogs, see S01.001 at
MEROPS—http://merops.sanger.ac.uk). EgKU-3 inhibited with high affinity both peptidases;
Fig 2A shows a representative experiment with the bovine enzyme and Table 2 the global inhi-
bition constants calculated for the two chymotrypsins. The values of KI

were of the same
order (53 ± 19 and 84 ± 49 pM for the bovine and canine enzymes, respectively) indicating no
bias in specificity towards any of them. EgKU-3 also inhibited elastase, although with substan-
tially lower affinity than chymotrypsins (KI

of 5 ± 2 nM).
Table 1. Screening of serine peptidase inhibitory activity of EgKUs.
P1a Trypsinb Chymotrypsinb
EgKU-1c Q NId NId
EgKU-2 W NDe High
EgKU-3 L NId High
EgKU-4 R Low NDe
EgKU-5 R High NDe
EgKU-6 R High NDe
EgKU-7 R High NDe
EgKU-8c R High Low
The activity was considered “high” when curvatures were observed in titration assays (initial steady-state
rate versus enzyme concentration plots) and the KI* values were < 10−10 M. The activity was considered
“low” when titration plots were linear and the KI* values were > 10−9 M. Refer to Fig 1 and the text for further
details.
aAmino acid at position 15 (numbering as per mature BPTI), corresponding to the active site of serine
peptidase inhibitors.
bThe assays were carried out with cationic trypsin and chymotrypsin A from bovine pancreas.
cData with recombinant EgKU-1 and EgKU-8 reproduced those obtained with the native proteins ([3]; see
the text for further details).
dNI, not inhibited.
eND, not determined.
doi:10.1371/journal.ppat.1006169.t001
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In order to study the inhibition mechanism of EgKU-3 towards chymotrypsins, we carried
out time course experiments with chymotrypsin A. The progress curves for the inhibition (Fig
2B) indicated that the enzyme-inhibitor complex reaches equilibrium in a time scale of min-
utes and that EgKU-3 is a slow-binding inhibitor as defined by Morrison [23]. The interaction
of EgKU-3 with chymotrypsin was reversible, since progress curves reached appreciable slopes
even at higher than stoichiometric inhibitor concentrations. This is the expected behavior for
Kunitz-type inhibitors [10] and the one observed for EgKU-8 [3]. Similarly, the plot of the
apparent rate constant (kobs) versus EgKU-3 concentration was hyperbolical (Fig 2C), in accor-
dance with a mechanism involving two steps, a fast initial binding of the inhibitor to the target
enzyme followed by a slow transition [24]. The kinetic constants of EgKU-3 binding to chymo-
trypsin obtained from analyses of the progress curves are shown in Table 3. Note that the
value of KI

calculated from the kinetic constants compared very well with the value obtained
through the fit of steady-state rate versus inhibitor concentration data to the Morrison equa-
tion (Table 2).
EgKU-1 and EgKU-4 block voltage-activated potassium channels (Kv)
As already mentioned, our results indicate that the paralogs EgKU-1/EgKU-4 do not show the
typical serine peptidase inhibitory activity of Kunitz-type inhibitors. In fact, EgKU-1 did not
inhibit any assayed peptidase [3]; whereas EgKU-4 inhibited trypsin albeit with low affinity,
with a KI

of 47 ± 2 nM, i. e. 1000-fold higher than the KI

of EgKU-3 and EgKU-8 versus their
target enzymes (Table 2). In view of these results and taking into account the structural simi-
larity between EgKU-1 and α-DTX [3], we analyzed whether EgKU-1 and EgKU-4 acted on Kv
Fig 1. Titration assays of recombinant EgKUs: results for EgKU-3 and EgKU-4. Increasing concentrations of bovine chymotrypsin or trypsin were
pre-incubated with fixed amounts of recombinant EgKU-3 (A) or EgKU-4 (B), respectively, and mixed with the corresponding enzyme substrate. The plots
show the initial steady-state rate of substrate hydrolysis for each enzyme concentration; the activity in the absence of inhibitor is indicated in grey. (A)
EgKU-3 is a high affinity inhibitor of chymotrypsin. Note that the slope at the enzyme concentrations for which activity is detected compares very well with
the slope in the absence of inhibitor. The x-intercept of this plot (1.5 nM) represents the enzyme concentration interacting with 1.5 nM of EgKU-3. Thus,
EgKU-3 inhibits chymotrypsin with a 1:1 stoichiometry. (B) EgKU-4 is a low affinity inhibitor of trypsin. Note that trypsin activity is detected all over the
assayed enzyme range in the presence of an inhibitor concentration 1000-fold higher than the peptidase concentration. Representative results are shown.
Experiments with EgKU-3 and EgKU-4 were carried out five and two independent times, respectively. Within each experiment, measurements were
performed in duplicates.
doi:10.1371/journal.ppat.1006169.g001
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Fig 2. Inhibition studies with EgKU-3: results for bovine chymotrypsin A. (A) Enzyme inhibition. The enzyme (1 nM) was preincubated for 15 min
with EgKU-3 (0.1–3.0 nM) and mixed with substrate (Suc-Ala-Ala-Pro-Phe-AMC, 5 μM) in 50 mM Tris-HCl, pH 8.0, 0.01% Triton X-100, at 37˚C. Initial
steady-state rate measurements were performed in duplicates and the experiment was repeated 5 independent times. A representative experiment is
shown. KI*app values at equilibrium were determined using Eq (1) for tight binding inhibitors as described in Materials and Methods. The solid line
represents the best fit to this equation. (B) Representative progress curves for the inhibition. The enzyme (1 nM) was added to reaction mixtures
containing the substrate (Suc-Ala-Ala-Pro-Phe-AMC, 5 μM) and increasing concentrations of EgKU-3 (0, 0.5, 1, 2, 3, 6, and 15 nM, gray traces) in 50 mM
Tris-HCl, pH 8.0, 0.01% Triton X-100, at 37˚C. The black traces represent the best fit to Eq 3, from which kobs were obtained. (C) Dependence of kobs on
the concentration of inhibitor. The enzyme was added to reaction mixtures containing the substrate (Suc-Ala-Ala-Pro-Phe-AMC, 5 μM) and increasing
concentration of EgKU-3 in 50 mM Tris-HCl, pH 8.0, 0.01% Triton X-100, at 37˚C. The enzyme concentrations were: 1 nM for 0.5–3 nM of EgKU-3, 2 nM
for 3–6 nM of EgKU-3, and 3 nM for 6–10 nM of EgKU-3. kobs values were obtained from time course experiments according to Eq 3 and correspond to the
average of at least two time courses. The black trace represents the best fit to Eq 5 in agreement with Eq 4. The experiment was repeated 3 independent
times.
doi:10.1371/journal.ppat.1006169.g002
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using whole-cell patch-clamp assays on neurons isolated from DRG. Both EgKUs inhibited Kv;
Fig 3A illustrates the effect of recombinant EgKU-1. The blockade was more pronounced over
the steady-state component of the current than over the peak current: 25 ± 11% versus 20 ±
14% and 27 ± 12% versus 23 ± 7% for 200 nM of recombinant EgKU-1 and EgKU-4, respec-
tively (n = 7). We also tested the activity of native EgKU-1 and verified that the recombinant
inhibitor reproduced reasonably well the behavior of the native inhibitor (100 nM of native
EgKU-1 blocked the steady-state current by 19% and the peak current by 10%; n = 4). Thus,
the effect appeared to be stronger on the currents at the end of the pulse (accounting for non
inactivating -delayed-rectifier- K+ currents, IKDR) than on those at the beginning of the pulse
(corresponding to fast -transient A-type- K+ currents, IKA). The effect was only partially
reversible because about 60% persisted 3 min after washing (Fig 3B). In addition, it was clearly
observed on the currents elicited over -40 mV, as highlighted by the activity profile of the
EgKUs over the K+ currents activated by different voltages (Fig 3D–3F). In contrast, the perfu-
sion of 1 μM EgKU-8 (n = 7) produced no significant changes in the peak amplitude (2.6 ±
3.2%, P = 0.20) or the steady-state current (1.1 ± 3.5%, P = 0.38), whereas 1 μM of EgKU-3
(n = 10) produced a slight non-significant reduction of the peak current (6.3 ± 3.8%, P = 0.13)
Table 2. Global inhibition constants (KI*) of EgKU-3, EgKU-4 and EgKU-8 acting on pancreatic serine peptidases.
KI*(pM)a
Trypsinb Chymotrypsin Ab Chymotrypsin Bb Elastaseb
EgKU-3 NIc 53 ± 19 84 ± 49 (5 ± 2) x 103
EgKU-4 (47 ± 2) x 103 NDd NDd NDd
EgKU-8e 60 ± 13 (2.0 ± 0.2) x 103 NIc NIc
BPTIf 0.6 1.3 x 103 NIg 2.6 x 106
aKI*, the global equilibrium dissociation constants, were calculated from inhibition assays (see Fig 2A) according to Eq 1 for tight-binding inhibitors and
minimally corrected for the effect of substrate concentration according to Eq 2. Values correspond to averages of independent experiments ± the standard
error (n 3, except for EgKU-4 in which case n = 2).
bBovine cationic trypsin and chymotrypsin A, canine chymotrypsin B, and porcine elastase were used as target enzymes.
cNI, not inhibited.
dND, not determined.
eData are from native EgKU-8, as reported in [3].
f Data are from MEROPS (I02.001).
gThe lack of inhibition refers to bovine chymotrypsin B [66].
doi:10.1371/journal.ppat.1006169.t002
Table 3. Inhibitory kinetics of EgKU-3 on bovine chymotrypsin A.
Kinetic constant Chymotrypsin
k2a (1.2 ± 0.2) x 10−2 s-1
KIa 3.2 ± 1.2 nM
k2/KIa (3.8 ± 2.0) x 106 M-1 s-1
k
-2
b (2.8 ± 2.3) x 10−4 s-1
KI*c 73 ± 30 pM
ak2, KI and k2/KI were calculated from time course experiments (see Fig 2B and 2C) according to the fit to Eq
5 of kobs versus [I] plots. Values are averages of independent measurements ± the standard error (n 2).
bk
-2 was calculated from time course experiments according to Eq 6. The value is the average of
independent measurements ± the standard deviation (n = 15).
cKI* was calculated from Eq 7 using the values of k2, KI and k-2 obtained from time course experiments. The
value is the average of independent measurements ± the standard error (n 3).
doi:10.1371/journal.ppat.1006169.t003
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and had no effect on the steady-state current (4.1 ± 4.5%, P = 0.13) (Fig 4). We also analyzed
the effect of EgKU-1 and EgKU-4 on voltage-activated sodium channels (Nav) and observed
no effect (S1 Fig).
Fig 3. Inhibition studies with EgKU-1 and EgKU-4: results for Kv from DRG neurons. Representative
experiments showing that recombinant EgKU-1 (200 nM) (A) blocks voltage dependent K+ currents elicited by
a pulse of -100 to 0 mV during 800 ms (holding potential Vh = -60 mV); and (B) that the inhibition effect is only
partially reversible after washout of the inhibitor. (C)–(F) Effect of the EgKUs on K+ currents activated by
increasing voltage pulses. The K+ currents were recorded following stepwise increments of 10 mV of the
membrane voltage between -110 and 30 mV from a holding potential of -60 mV. Recordings showing the
effect of recombinant EgKU-1 (200 nM) are shown in (C) and the current-voltage relationship of these traces
in (D). Similar analyses with native EgKU-1 (100 nM) and recombinant EgKU-4 (200 nM) are shown in (E) and
(F), respectively. The black traces correspond to control conditions and the gray ones after EgKU perfusion.
Note that the effects of native and recombinant EgKU-1 are of the same order.
doi:10.1371/journal.ppat.1006169.g003
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Subsequently, we further characterized the effect of EgKU-1 and EgKU-4 on Kv. For this
purpose, we recorded the currents after a pre-pulse of -120 mV to activate all voltage-depen-
dent K+ currents, transient IKA as well as slow-inactivating IKDR; and also those remaining
when the pre-pulse was of -45 mV, voltage at which IKA is inactivated. Thus, the second
recording corresponded to IKDR; whereas IKA could be deduced by subtracting IKDR from the
first recording. A representative experiment with recombinant EgKU-1 is shown in Fig 5.This
setup allowed us to analyze the effect of the inhibitors on total K+ currents (Fig 5A and 5C) as
well as on both types of isolated K+ currents, IKDR (Fig 5B and 5D) and IKA (Fig 5E). As antici-
pated by the previous experiment, EgKU-1 principally affected IKDR, with virtually no effect
on IKA (Fig 5D versus 5E). Finally, we studied the concentration-response relationship for
native EgKU-1 and estimated an IC50 of about 200 nM when acting on all K+ currents activated
by a pulse of -100 to 0 mV (Fig 6). Although we did not determine the IC50 for EgKU-4, its
behavior was similar to the one of EgKU-1.
EgKU-1 and EgKU-4 block Acid Sensing Ion Channels (ASICs)
Taking into account the recently described activity of α-DTX on ASIC currents in DRG neu-
rons [22], we also analyzed the effect of EgKU-1 and EgKU-4 on pH-dependent Na+ currents.
The sustained application of both EgKUs blocked the ASIC currents elicited by a pH change
from 7.4 to 6.1. The blocking effect was on the peak amplitude (Ipeak) and no significant effect
was observed on the desensitization time course (τdes). The effect on the current amplitude
was fully reversible after 1 min washing (Fig 7A–7C). We similarly analyzed the effect of
EgKU-3 and EgKU-8: EgKU-3 (n = 8) produced a slight but significant decrement of the Ipeak
(6.4 ± 3.0%; P = 0.02), whereas EgKU-8 (n = 7) had no effect (6.2 ± 5.1%; P = 0.11) (Fig 7D–
7E). Finally, we studied the concentration-response relationship for native EgKU-1 (Fig 8A);
the estimated IC50 value (about 8 nM) was 25-fold lower than the one determined for Kv
(about 200 nM), suggesting higher selectivity of EgKU-1 for ASICs than Kv.
Fig 4. Studies with EgKU-3 and EgKU-8 on total K+ currents from DRG neurons. Representative
experiments showing that recombinant EgKU-3 and EgKU-8 (1 μM) do not block voltage-dependent K+
currents elicited by a pulse of -100 to 0 mV during 800 ms (Vh = -60 mV). The superimposed traces
correspond to control recordings (black) and records after the perfusion of each EgKU (red). Positive and
negative controls were carried out in parallel, using α-DTX (100 nM) and albumin (15 μM), respectively.
doi:10.1371/journal.ppat.1006169.g004
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The EgKUs may be detected in metacestode and adult worm secretions
In our previous study, using mass spectrometry analysis, we showed that members of the
Kunitz family, notably EgKU-3 and EgKU-8, would be present in protoscolex secretions from
untreated and pepsin/H+-treated larval worms [3]. To further approach the question of
whether Kunitz inhibitors are secreted to the parasite-host interface, we similarly analyzed
hydatid fluid and adult worm secretions. Fig 9A shows a representative MALDI-TOF MS pro-
file (5000–10000 Da) of hydatid fluid from bovine cysts. Peaks of m/z 6407.5 and 6519.6,
matching the predicted MH+ value for EgKU-3 (6406.4 Da) and EgKU-8 (6520.4 Da), respec-
tively, were observed. Furthermore, the intensity of the signals putatively corresponding to
both EgKUs was substantially increased in the chymotrypsin A-affinity purified fraction from
the same sample (Fig 9B). In addition, the MS profile of an analogous fraction from the super-
natant of in vitro cultured immature adults (Fig 9C) also showed peaks matching the predicted
MH+ value for EgKU-3 and EgKU-8 (m/z of 6409.8 and 6521.3, respectively). Peptide mass fin-
gerprinting of the components purified from cyst fluid allowed the detection of signals that
could be assigned to tryptic peptides of these EgKUs. In particular, we detected signals with m/
Fig 5. Inhibition studies with EgKU-1 on isolated K+ currents from DRG neurons. Blocking effect of recombinant EgKU-1 (675 nM) on isolated K+
currents activated by increasing voltage pulses. (A) Voltage-dependent K+ currents (fast -transient A-type- currents, IKA; as well as non inactivating
-delayed-rectifier- currents, IKDR) were recorded from a holding potential of -100 mV, following stepwise increments of 10 mV of the membrane voltage,
between -65 and 55 mV. (B) IKDR currents were similarly recorded from a holding potential of -45mV, so as to inactivate IKA currents. (C) and (D) are the
corresponding current-voltage plots of (A) and (B), whereas (E) is the current-voltage plot accounting for IKA currents and was obtained by subtracting (D)
from (C).
doi:10.1371/journal.ppat.1006169.g005
Fig 6. Concentration-response analysis of native EgKU-1 on total K+ currents from DRG neurons. (A) Representative traces showing total K+ currents
elicited by a voltage pulse of -100 to 0 mV during 1000 ms (as indicated above the current trace) under control conditions, after 1 min perfusion of 200 nM of
native EgKU-1 and after washing. (B) Concentration-response analysis of EgKU-1 inhibitory effect on K+ currents, measured at the end of the voltage pulse,
on the steady-state component of the current. The black line shows the best fit to the dose-response equation, from which the IC50 was calculated (216 ± 26
nM). The data correspond to the mean ± standard error (n = 5 in all cases). The asterisks indicate Student’s t-test significance with respect to the effect in the
absence of inhibitor (P 0.05).
doi:10.1371/journal.ppat.1006169.g006
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z values 1074.54 and 1491.63 that corresponded to EgKU-8 sequences 7LPLDPGFCR15 and
21WGFHQESGECVR32 with S-carboxymethylated cysteines (theoretical m/z values 1074.53
Fig 7. Inhibition studies with EgKU-1 and EgKU-4: results for ASIC currents from DRG neurons. (A-C)
Representative traces showing the acid (pH 6.1, 5 s) activated current under control conditions (left), after sustained (25
s) perfusion of 30 nM of each EgKU (center) and after 1 min washout of the inhibitors (right). Note that EgKU-1 and
EgKU-4 reduced the amplitude of the Na+ current, that recombinant EgKU-1 reproduced the effect of the native inhibitor
and that the recovery after washout was higher than 90% in all cases. (D-E) Representative traces from analogous
assays with 30 nM of EgKU-3 and EgKU-8. The slight decrement of the current amplitude induced by EgKU-3 was
significant (see the text for further details); EgKU-8 had no effect. (F) Albumin (15 μM) was used as negative control.
Calibration in each case applies to the control, effect and washout recordings of each panel.
doi:10.1371/journal.ppat.1006169.g007
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and 1491.64, respectively; see Fig 10C). In addition, a signal corresponding to EgKU-3
sequence 49–57 was detected in the same spectrum. MS/MS analysis of the corresponding ions
further corroborated the amino acidic sequences (S1 Dataset). Note that, although lower than
towards trypsins, the affinity of EgKU-8 towards chymotrypsin A (KI

10−9 M; Table 2) was
high enough to allow its purification from the secretions. In contrast, this approach is not suit-
able to purify EgKU-1 and EgKU-4 that have no affinity towards chymotrypsin; thus, even if
they had been present in the original sample, we would not have detected them.
Discussion
In the present study, we described the functional characterization of eight members of the E.
granulosus family of secreted Kunitz inhibitors (EgKUs). Using recombinant forms of EgKU-
1-EgKU-8 and native EgKU-1, we demonstrated that six EgKUs behave as high affinity inhibi-
tors of either chymotrypsin (EgKU-2 and EgKU-3) or trypsin (EgKU-5-EgKU-8), whereas the
close paralogs EgKU-1/EgKU-4 act as cation channel blockers (of Kv as well as ASICs), while
showing either null (EgKU-1, our previous study [3]) or marginal (EgKU-4) serine peptidase
inhibition activity. This degree of functional diversity, commonly observed in animal venoms,
had not been previously described for Kunitz inhibitors present in parasite secretions.
Regarding serine peptidase inhibition, detailed kinetic studies showed that the interaction
of EgKU-3 with chymotrypsins mimics the one of the close paralog EgKU-8 with trypsins: it is
slow, of very high affinity and involves two steps. EgKU-3 strongly inhibited isoforms A and B
of chymotrypsin with KI

in the 10−11 M range. Notably, according to MEROPS, dogs have
two chymotrypsins B (with > 95% identity, encoded by CTRB1 and CTRB2 genes) and lack
chymotrypsin A. The values of KI

are among the smaller registered for chymotrypsin inhibi-
tors. In fact, only two peptides have been reported to have similar affinity, both towards bovine
chymotrypsin A (see S01.001 in MEROPS) [25,26]. No high affinity inhibitors of chymotrypsin
B have been described so far, most likely because very few studies have been carried out with
this isoform (see S01.152 in MEROPS). Therefore, EgKU-3 appears as an interesting titration
reagent for chymotrypsins A and B, especially for the latter because adequate titration reagents
are currently unavailable. The stability of the EgKU-3-chymotrypsin A complex is similar to
that of EgKU-8 complexes with trypsins, with k2/KI, the apparent second order rate constant
for complex formation (kon), in the 106 M-1 s-1 range; and the dissociation rate constant (k-2)
in the 10−4 s-1 range (Table 3 and our previous study, [3]). These values of k2/KI are in good
agreement with reports for other members of the family, including BPTI with bovine trypsin
[27], whereas those of k-2 are several orders faster than the one reported for BPTI (10−8 s-1 with
bovine trypsin [27]).
The activity of EgKU-3 as a strong tight-binding inhibitor of chymotrypsins and a less
potent inhibitor of pancreatic elastase, as well as its lack of activity towards trypsin (Table 2)
are consistent with the presence of a Leu in P1. In turn, similar to BPTI (Lys in P1), EgKU-8
(Arg in P1) strongly inhibits trypsins, less potently chymotrypsin A and does not inhibit
Fig 8. Concentration-response analysis of native EgKU-1 on ASIC currents from DRG neurons. (A)
Analysis of native EgKU-1 inhibitory effect on the ASIC current amplitude (n = 26). The black line shows the
best fit to the dose-response equation, from which the IC50 was calculated (7.8 ± 0.7 nM). The data
correspond to the mean ± standard error (n 6 in all cases, except for 1 nM in which n = 4). The asterisks
indicate Student’s t-test significance with respect to the effect in the absence of inhibitor (P 0.05). (B) and
(C) correspond to positive and negative controls, respectively. (B) Representative traces showing the acid (pH
6.1, 5 s) activated current under control conditions (left), after sustained (25 s) perfusion of α-DTX (center),
and after 1 min washout (right). α-DTX (1 μM; n = 6) significantly decreased the current amplitude
(44.5 ± 7.0%; P = 0.045). (C) The application of EgKU-1 in extracellular solution, without any pH change, had
no effect.
doi:10.1371/journal.ppat.1006169.g008
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Fig 9. Detection of EgKU-3 and EgKU-8 in parasite secretions. Analysis by MALDI-TOF MS of hydatid fluid from
a bovine cyst (A), as well as of chymotrypsin-affinity purified fractions from the same sample (B) and from the
supernatant of cultured immature adults (C). Signals whose m/z values could derive from the EgKUs are indicated
(MH+ predicted for mature EgKU-3 and EgKU-8 are: 6406.8 and 6520.9, respectively). Note that the signals
putatively corresponding to the EgKUs are significantly enriched in the eluate from the affinity matrix. The identity of
EgKU-3 and EgKU-8 purified from cyst fluid was subsequently confirmed by peptide mass fingerprinting (see S1
Dataset and the text for further details), as previously described [3].
doi:10.1371/journal.ppat.1006169.g009
Fig 10. Structural analyses of EgKU-1/EgKU-4 and EgKU-3/EgKU-8. (A) Cartoon representation of structural models from the EgKUs and the crystal
structure of α-DTX (1DTX) featuring solvent-accessible (> 40 Å2) aromatic (purple), acid (red) and basic (blue) residues. N and C terminal ends are
labeled. Note the presence of patches of basic amino acids with close aromatic residues in the models of α-DTX, EgKU-1 and EgKU-4. (B) Molecular
surface electrostatic representations of the same proteins in the same orientation, highlighting global differences in charge distribution; scale represents
charge from positive blue to negative red. (C) Sequence alignment produced with TEXshade [82] and hand-edited, featuring aromatic, acid and basic
residues; those with solvent-accessibilities < 40 Å2 are grey shaded. Note that structurally equivalent positions in the EgKUs and α-DTX are shifted two
residues in the primary sequence. The P1 site of serine peptidase inhibitors, located at the center of the antipeptidase loop, is indicated with arrowheads in
(A) and (C).
doi:10.1371/journal.ppat.1006169.g010
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elastase (Table 2). Notably, neither EgKU-8 nor BPTI inhibit chymotrypsin B. The antipepti-
dase loops of EgKU-3 and EgKU-8 differ by 50% (the corresponding mature polypeptides dif-
fer by only 37%); differences are mainly on the P side of the loop (residues 10 to 15), and
involve some non-conservative substitutions (notably Asp10 instead of Lys10 in P6; see Fig
10C). Because the loop contributes to the inhibition specificity primarily determined by the P1
site, some of these residues are likely involved in the interaction with chymotrypsin B. In any
case, consistent with the fact that isoforms A and B have similar affinities towards substrates
with Phe as P1 residue [28], the values of KM for the substrate we used were of the same order.
Regarding cation channel inhibition, patch-clamp studies carried out on rat DRG neurons
showed that EgKU-1 and EgKU-4 block voltage-activated potassium currents. The effect was
voltage-dependent and, as described for dendrotoxins, it was not totally reversible (Fig 3;
[29]). The detailed characterization of EgKU-1 activity on isolated K+ currents indicated that it
preferentially blocks IKDR, as compared to IKA. This behavior differs from the one of α–DTX
and resembles the one of δ–DTX [29]. In any case, the IC50 determined for EgKU-1 was two
orders of magnitude higher than those of dendrotoxins assayed on DRG neurons (10−7 versus
10−9 M [29]). This could be due, at least in part, to the fact that, although EgKU-1 shares with
dendrotoxins several residues that would participate in channel interaction (notably Leu7,
Lys26 and Lys27), it lacks the Lys5 that has been described as a primary determinant of activity
([21]; this is also the case for EgKU-4 that shares Leu7 and Lys27 with α–DTX and EgKU-1;
see Fig 10C). Because we studied the effect of the EgKUs on total Kv currents of primary cul-
tures, we cannot comment on their activity over specific Kv. Nevertheless, our results indicate
that EgKU-1 could be more active over some Kv than others. Indeed, the dose-response curve
does not start from zero (Fig 6), as if a specific Kv was highly blocked at low concentrations of
the inhibitor.
EgKU-1 and EgKU-4 also showed a potent dose-dependent blocking effect on the ASIC cur-
rents in DRG neurons, which was totally reversible after one minute washing (Fig 7). These
neurons express at least two subpopulations of transient ASIC currents as judged by their inacti-
vation constants [30]. One of them derives from channels of ASIC1a, ASIC1b and ASIC3 sub-
units; the other from channels of ASIC2a subunits (reviewed by [31]), which are the least
expressed in DRG [32]. Although our experimental setup does not allow us to conclude which
channels are sensitive to the EgKUs, the dispersion of the values in the dose-response study with
native EgKU-1 (Fig 8A) points to some variability of the blocking effect among different cells,
suggesting that the effect could be stronger for some channel(s). EgKU-1 could thus mimic the
performance of other peptide blockers of ASICs, such as APETx2 (reviewed by [31]).
We recently reported that α-DTX, the well-known blocker of voltage activated K+ channels,
also inhibits ASIC currents in rat DRG, although with significantly less potency than Kv (IC50
~ 10−7 M [22] versus 10−9 M [29], respectively; see also Figs 4 and 8B). This result indicates
that the Kunitz domain is yet another structural scaffold for ASIC-blocking polypeptides.
Interestingly, an exposed basic-aromatic cluster identified in structurally different ASIC
blocking peptides [33] was also found to be present in the structure of α-DTX [22]. Notably,
this feature is observable towards one side of the model structures of EgKU-1 and EgKU-4 and
not in those of EgKU-3/EgKU-8 (Fig 10A). In any case, functionally distinct EgKUs differ
mainly in surface charge distribution (Fig 10B). The relatively low selectivity of Kunitz inhibi-
tors towards cation channels contrasts with the high specificity of their interaction with serine
peptidases. Not surprisingly, structure-activity analyses focused at identifying the “channel-
blocking site” of Kunitz proteins have usually highlighted regions on their surface involved in
channel interaction but not a defined structural motif comparable to the antipeptidase loop
involved in serine peptidase interaction. Furthermore, key residues for channel blockade are
frequently located in the N- or C-terminal extensions of the Kunitz domain [17,34]
Functional diversity of cestode Kunitz inhibitors
PLOS Pathogens | DOI:10.1371/journal.ppat.1006169 February 13, 2017 17 / 33
The availability of the E. granulosus genome [5,35] has allowed us to identify genes coding
for at least eight additional monodomain Kunitz proteins with the same molecular architecture
as EgKU-1–EgKU-8, i. e. a signal peptide followed by a single Kunitz domain. Similar to the
rest of the family, the newly-identified members are diverse and include several pairs of close
paralogs, consistent with an accelerated evolution of the family. Fig 11 shows an unrooted phy-
logenetic tree of the Kunitz domains from the sixteen EgKUs together with eleven close para-
logs from T. solium and five from functionally characterized monodomain Kunitz proteins
from Lophotrochozoa, including four from trematodes. A true phylogenetic tree is not in-
tended, as the signal might be blurred by homoplasy. Rather, the tree is aimed to mirror func-
tional groupings of the sequences in an approximate evolutionary context. Not surprisingly,
the sequences from T. solium pair with their close E. granulosus paralogs. The groupings
roughly correlate with functional features, whereas EgKU-2 (and a putative T. solium ortholog)
appears very distant from the rest. The red sub-clade includes several serine peptidase inhibi-
tors: in addition to EgKU-3/EgKU-8 and EgKU-5, EGR_07242 (EgKI-2 in [36]) and the schis-
tosome proteins SjKI-1 [37] and SmKI-1 [38]. EGR_07242 (Arg in P1) was recently found to
inhibit trypsin, although with relatively low affinity (KI ~ 10−9 M; [36]), probably due to the
lack of Cys14, i. e. the one forming the disulphide bond that stabilizes the antipeptidase loop.
SjKI-1 and SmKI-1 (both with Arg in P1) also inhibit trypsin with IC50 in the 10
−10 and 10−8
M range, respectively [37,38]. The green sub-clade appears to group a different set of serine
peptidase inhibitors (EgKU-6/EgKU-7 and closely related proteins from T. solium). In turn,
the blue sub-clade includes the channel blockers EgKU-1/EgKU-4 together with another pair
of close E. granulosus paralogs (EgrG001136600/EgrG001137000), and two T. solium proteins
(TsM_000410200 and TsM_000513000). Although it is difficult to predict their function
without further data, these proteins could also act as channel blockers because, similar to
EgKU-1/EgKU-4, they feature the conserved Leu7 and a positively charged β–turn that form
the Kv-blocking site of α-DTX and related toxins [34,39,40,41]. As to the other groupings,
EgrG_001136500 (Leu in P1) was recently found to be a potent inhibitor of neutrophil elastase
(KI ~ 10−11 M) and cathepsin G (KI ~ 10−10 M) and, interestingly, to reduce neutrophil infiltra-
tion in a local inflammation model (EgKI-2 in [36]); thus, its close paralog (EgrG_00113800;
Arg in P1) could also be a serine peptidase inhibitor. Finally, the sequences from Fasciola
hepatica (FhKTM [42] and FhKT1 [43], both with Leu in P1, whose Kunitz domains differ
in 3/51 amino acids) define a basal, separate sub-clade, that could also reflect functional diver-
sity: FhKTM was found to be a marginal inhibitor of trypsin with virtually no effect over chy-
motrypsin [42] but, notably, FhKT1 was recently characterized as an inhibitor of cysteine
peptidases, including the major parasite cathepsin L secreted peptidases and related human
peptidases [43]).
Another interesting finding of our work refers to the demonstration of the presence of
some EgKUs (notably, EgKU-3 and EgKU-8) in cyst fluid (from bovine cysts) and secretions
from immature adult worms, which complement our previous results with secretions from
protoscoleces and pepsin/H+-treated protoscoleces [3]. EgKU-8 was also detected by proteo-
mic analyses in fertile cyst fluids from ovine and human infections, but not in infertile cysts
from infected cattle [44]. Members of the Kunitz family could thus be secreted to the E. granu-
losus-dog interface not only at the initial stages of infection (as indicated by their presence in
larval worm secretions) but also at late stages, and contribute to the establishment and persis-
tence of dog echinococcosis. In turn, their presence in cyst fluid would point to a role at the
onset of infection in dogs and/or during the chronic stage of infection in intermediate hosts.
In addition, available RNASeq data [5,35] indicate that members of the family are expressed
in all the analyzed stages (immature adult, activated oncosphere, cyst, protoscolex, pepsin/H+-
treated protoscolex); interestingly, most EgKUs are expressed in adults. Furthermore, several
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Fig 11. Expanded view of the E. granulosus Kunitz family. Unrooted phylogenetic tree highlighting
sequence groupings within the family that roughly correlate with functional features described in the main text.
Of outmost notice are sub-clades which include pairs such as the serine peptidase inhibitors EgKU-3/EgKU-8
(red clade) and EgKU-6/EgKU-7 (green clade); and the channel blockers EgKU-1/EgKU-4 (blue clade). Note
that the sequences from T. solium pair with their close E. granulosus paralogs. Interestingly, the serine
peptidase inhibitors SjKI-1 [37], SmKI-1 [38] and EGR_07242 (EgKI-2 in [36]) group in the red clade. The
sequences from F. hepatica (FhKTM [42] and FhKT1 [43]) define a basal, separate clade that could reflect
functional diversity (cysteine peptidase inhibition; [43]). The long branch of EgKU-2 (and its putative T. solium
ortholog) may reflect either a basal position of the protein (ancient/extreme sequence divergence), an
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of them appear up-regulated in this stage, notably, EgKU-3, EgKU-7, EgKU-8, and also
EGR_07242 and EgrG_0001137000 [35]. In addition, the orthologs of EgKU-1 and EgKU-4
were found to be highly up-regulated in E. multilocularis gravid adults (as compared to non-
gravid worms) [5], whereas EgrG_001136500 and a close paralog (EmuJ_001136900) were
among the transcripts with higher expression in oncospheres from E. granulosus [35] and E.
multilocularis [45], respectively. Together with our results highlighting the presence of EgKUs
in parasite secretions, these data support the concept that Kunitz proteins are involved in para-
site interaction with definitive and intermediate hosts, and indicate that specific members of
the family would be engaged in particular moments of the life-cycle.
Given the activity profile of EgKU-1-EgKU-8 and the fact that they are mostly expressed
and secreted by larval and adult worms [3,35], we can speculate about their potential counter-
parts in the dog duodenum. The apical end of the scolex contains a gland (the rostellar gland)
whose secretion is believed to play a key role in host-parasite cross-talk, due to the very inti-
mate contact of the scolex with the mucosa (reviewed by [2]). Interestingly, seminal studies
demonstrated that the rostellar gland secretion is cystine-rich [46]; the gland could thus be the
site of synthesis and concentration of the EgKUs. Pancreatic enzymes appear as clear targets of
the EgKUs acting as serine peptidase inhibitors: those present in cyst fluid could initially pro-
tect the larval worms from digestion; whereas those secreted could protect the scolex (whose
glycocalix is thin) after the parasite has attached to the mucosa. The EgKUs could also inhibit
other serine peptidases, such as those secreted by immune cells (see for example [47]) and
membrane peptidases from epithelial cells (see for example [48,49]); in turn, this effect could
prevent the activation of proteinase-activated receptors (PARs; [50]). As to putative targets of
EgKU-1/EgKU-4, very little is known about the expression and functional properties of Kv
and ASICs in the gut. In any case, both types of channels participate in the physiology of epi-
thelial cells and afferent neurons [51,52,53]. In addition, Kv and ASICs are involved in the acti-
vation and maturation of dendritic cells and macrophages. In particular, Kv1.3 and Kv1.5
modulate the Ca2+-dependent functions of these cells and their blockade down-regulates their
activation [54]. Regarding ASICs, dendritic cells express ASIC1, ASIC2 and ASIC3, and extra-
cellular acidosis induces currents that are blocked by ASIC inhibitors. In addition, acidosis
triggers the activation of dendritic cells and macrophages and ASIC inhibitors block these
effects [54,55]. Taking into account that extracellular acidosis is a hallmark of inflammation,
the blockade of ASICs may be crucial to weaken the induction of innate immunity and to
favor the development of a chronic infection. In this context, it is pertinent to mention that
excretory-secretory (E/S) products from E. granulosus adults have recently been found to
impair dendritic cell function and induce the development of regulatory T cells [56]. Further-
more, a similar result was observed with the Kunitz protein FhKTM from the trematode F.
hepatica, which is known to be present in parasite E/S products [57].As already mentioned,
FhKTM showed a marginal serine peptidase inhibitory activity [42] but, notably, the very
closely related FhKT1 (> 90% overall identity with FhKTM) was recently found to inhibit cys-
teine peptidases [43].
In our previous study, we included data from an extensive survey of platyhelminth ESTs
available at the time, indicating that the expression of families of monodomain Kunitz proteins
accelerated evolution (e.g. through positive selection) or even relaxed selective pressures resulting in high
tolerance to mutation accumulation. Data are insufficient to distinguish between such alternative scenarios.
EgrG_001136500, in a black clade to the left, was also found to be a potent serine peptidase inhibitor (EgKI-1
in [36]). The position of the mollusk sequence (Conkunitzin S1), which was characterized as a channel blocker
[14], is probably derived from the fact that, similar to EGR_07242, it lacks Cys14. This artifact is to be
expected in short sequences. Bottom scale bar denotes average substitutions per site.
doi:10.1371/journal.ppat.1006169.g011
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would be a distinctive trait of cestodes [3]. Genomic and transcriptomic data currently avail-
able (accessible from WormBase ParaSite: http://parasite.wormbase.org/; [58]) confirm and
extend these initial observations, in particular, for the other medically important cestodes, E.
multilocularis and T. solium, and indicate that this family is expanded in cestodes. Putative
orthologs of virtually all the EgKUs are present in the E. multilocularis genome, and several are
also predicted for T. solium (Fig 11). In addition, recent genome-wide analyses of E/S proteins
showed that the Kunitz domain is either the most (in E. multilocularis, 17/673 predicted E/S
proteins; [59]) or the third most (in T. solium, 14/838 predicted E/S proteins; [60]) represented
domain in the predicted secretome of these parasites, whereas manual inspection of the puta-
tive secreted Kunitz proteins indicates that a majority of them contain a single Kunitz domain.
In contrast, parasitic trematodes express only a few monodomain Kunitz inhibitors (see for
example [61]).
The secretion of monodomain Kunitz proteins thus appears to be a strategy evolved by ces-
todes to block, through high affinity interactions, the function of host proteins (either serine
peptidases or cation channels) and contribute to the establishment and persistence of infec-
tion. The putative immunomodulatory role of these molecules opens the way to further studies
of their involvement in immunoevasion, acting as single molecules as well as synergistically.
From a more general perspective, the data confirm that multigene families of Kunitz inhibitors
from parasite secretions and animal venoms display a similar functional diversity. As we had
previously mentioned, because the genes coding for parasite secretions and predator toxins
arise from an arms race between different organisms, it is interesting to consider that both sets
of molecules display analogous evolutionary patterns. Finally, the strong target specificity of
some of these molecules makes them uniquely suited as tools for the characterization of biolog-
ical processes as well as for the development of pharmaceuticals.
Materials and methods
Preparation of EgKUs
Native EgKU-1 and EgKU-8 were purified to homogeneity from a protoscolex lysate by cation
exchange followed by reverse-phase chromatography, as previously described [3].
EgKU-1–EgKU-8 [3] were overexpressed as amino-terminal His6-tagged fusion proteins in
Escherichia coli strain BL21(DE3) using pET28a recombinant plasmids prepared according to
standard procedures. The expression constructs included the His6 leader sequence followed by
the cDNA sequence encoding the corresponding predicted full-length mature EgKU. These
were amplified from E. granulosus pepsin/H+-activated protoscolex cDNA [62] using Vent
DNA polymerase (New England Biolabs) and specific primers containing restriction sites to
allow directional cloning into the pET28a vector. BamHI and HindIII sites were used except for
EgKU-6 and EgKU-7 whose coding sequences are cleaved by BamHI; EcoRI was used instead.
The integrity of the expression constructs was checked by sequencing. The His6-tagged EgKU
fusion proteins were expressed in transformed E. coli grown in LB containing 10 mg/L of kana-
mycin and induced at 37˚C with 0.1 mM isopropyl thiogalactopyranoside. Induction of expres-
sion was at late-log-phase (A600 0.6–1.0) during 4 h, in the case of the pairs of paralogs EgKU-1/
EgKU-4 and EgKU-3/EgKU-8 that yielded good amounts of soluble recombinant peptides [63].
Expression of EgKU-2, EgKU-5 and the paralogs EgKU-6/EgKU-7, whose recombinants are
recovered mostly as inclusion bodies [63], was induced earlier (A600 0.2–0.3) to maximize the
yield of the soluble proteins. In all cases, the induced cells were harvested by centrifugation, the
pellet was suspended in “lysis” buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole),
and the cells were lyzed by sonication. The lysates were centrifuged (20,000 g for 30 min at 4˚C)
and the supernatants used to purify the His-tagged fusion proteins using a Ni2+-charged affinity
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matrix (Ni-NTA, Invitrogen), following the manufacturer’s instructions. The soluble fraction of
the bacterial lysates was loaded onto the column equilibrated with lysis buffer, washed with
equilibration buffer including 30 mM imidazole, and the recombinant EgKUs eluted with the
same buffer containing 250 mM imidazole, that was subsequently dialyzed.
The purity of the EgKUs was checked by SDS-PAGE analysis and the protein concentration
was determined with the bicinchoninic acid reagent (BCA, Pierce, USA) using bovine serum
albumin as standard, or by A280. The quality of the recombinants was further controlled by: i)
confirming the presence of three disulphide bonds (i. e. that the proteins were fully oxidized)
through determination of the molecular masses of the EgKUs and their reduced and alkylated
derivatives by MALDI-TOF MS, as described by Calvete [64] (S2 Fig); ii) checking that recom-
binant EgKU-8 reproduced the performance of the native inhibitor towards bovine trypsin
and thus, that the recombinant was properly folded and the N-terminal extension contributed
by the expression vector did not interfere with enzyme interaction (Ki

was 50 ± 10 pM for
recombinant EgKU-8 and 60 ± 13 pM for the native inhibitor [3]); iii) during this study, we
also verified that recombinant EgKU-1 reproduced reasonably well the performance of the
native inhibitor acting on Kv and ASIC currents from DRG neurons (Figs 3 and 7, respec-
tively). Usual yields of the EgKUs recovered as soluble recombinants and used for activity
assays were as follows: ~5 mg/L of culture for EgKU-1/EgKU-4 and EgKU-3/EgKU-8; ~300 μg/
L for EgKU-7 (~30% of the total); and ~5 μg/L for EgKU-2, EgKU-5 and EgKU-6 (~5% of the
total). The purity of the proteins used for detailed activity studies (EgKU-1, EgKU-3, EgKU-4
and EgKU-8) was always> 95%.
Assays of peptidase inhibition by EgKUs
The inhibitory activity of recombinant EgKU-1–EgKU-8 was tested against bovine trypsin (EC
3.4.21.4), bovine and canine chymotrypsins (EC 3.4.21.1), and porcine elastase (3.4.21.36),
essentially as previously described [3]. Bovine enzymes and porcine elastase were obtained
from Sigma-Aldrich, whereas the canine peptidase was purified from the pancreas of a dog
that had passed away due to an accidental cause, following the procedure of Waritani et al.
[65]. According to MEROPS, dogs have two chymotrypsins B (with > 95% identity, encoded
by CTRB1 and CTRB2 genes); the fraction we isolated from dog pancreas most likely con-
tained a mixture of both enzymes.The following peptidases were thus assayed (MEROPS—
http://merops.sanger.ac.uk—identifiers are indicated in brackets; [9]): from Bos taurus, chy-
motrypsin A (S01.001) and trypsin 1 (cationic, S01.151); from Sus scrofa, elastase (S01.153);
from Canis familiaris, chymotrypsin B (S01.152)).
Prior to inhibition studies, proteolytic activity in enzyme preparations was determined with
fluorogenic substrates using initial steady-state rate conditions at 37˚C and pH 8.0. Assays
(200 μl) were performed in black 96-well microplates (Costar, Corning Life Sciences).
Enzymes and substrates were dissolved in 50 mM Tris-HCl, pH 8.0 containing 0.01% Triton
X-100 (v/v), and reactions were initiated by the addition of enzyme. The changes in fluores-
cence intensity, corresponding to the formation of the hydrolysis product 7-amino-4-methyl-
coumarin (AMC), were registered at excitation and emission wavelengths of 390 and 460 nm,
respectively, with a microplate fluorescence reader (FLUOstar OPTIMA, BMG Labtechnolo-
gies). For trypsin activity, the artificial substrate N-t-BOC-Ile-Glu-Gly-Arg-AMC was used;
for chymotrypsin, Suc-Ala-Ala-Pro-Phe-AMC; and for elastase, Suc-Ala-Ala-Ala-AMC. Cali-
bration curves using AMC were carried out in each experiment. Initial steady-state rates of
substrate hydrolysis were calculated from the linear portion of product (AMC) versus time
plots when less than 10% of substrate had been consumed. The substrates and AMC were also
obtained from Sigma-Aldrich.
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Protein concentrations of enzyme preparations were determined with the BCA reagent
using bovine serum albumin as standard; and the active site concentration of trypsin and
bovine chymotrypsin A by specific titration with the high affinity inhibitor BPTI. Initially, the
active site concentration of canine chymotrypsin could not be estimated because, similar to
bovine chymotrypsin B [66], it was not inhibited by BPTI. The enzyme was subsequently
titrated with EgKU-3 that inhibits chymotrypsins A and B with high affinity (see results).
The kinetic parameters for substrate and enzyme pairs were calculated from the non-linear fit-
ting to the Michaelis-Menten equation. The values determined with the substrates specified above
were: KM = 85 ± 9 μM and kCat = 50 ± 6 s-1 for bovine trypsin; KM = 30 ± 2 μM and kCat = 19 ± 2
s-1 for bovine chymotrypsin A; KM = 39 ± 2 μM and kCat = 6 ± 1 s-1 for canine chymotrypsin B.
For inhibition studies, each of the enzymes was incubated with the purified recombinant
EgKUs for 15 min at 37˚C prior to the addition of the appropriate fluorogenic substrate, to
allow for the equilibration of the enzyme-inhibitor complexes. The substrate concentration
(5 μM) was chosen so as to be well below the corresponding KM, as specified above.
To check whether the EgKUs behaved as high affinity inhibitors, the purified recombinants
were titrated against active-site titrated bovine trypsin and chymotrypsin, as described by
Olson et al. [67].
Peptidase inhibition studies with EgKU-3 and EgKU-4
The activities of EgKU-3 and EgKU-4 were further analyzed by characterizing the kinetics of
enzyme inhibition, as previously described for EgKU-8 [3]. All experiments were carried out at
least two independent times. Within each experiment, measurements were performed in
duplicates. The inhibition and rate constants reported are the average ± standard error of inde-
pendent experiments.
Tight-binding kinetics. In order to determine the global inhibition constants (KI

) of the
recombinant inhibitors towards the assayed serine peptidases, the initial steady-state rates of
substrate hydrolysis in the presence of increasing concentrations of each inhibitor were mea-
sured after pre-incubation of the enzyme with inhibitor. The inhibition constants were calcu-
lated by nonlinear fitting to the Morrison equation for tight binding inhibitors [68,69]:
vi ¼
v
2½E
fð½E   ½I   KI appÞ þ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð½I þ KI app   ½EÞ
2
þ 4KI app½E
q
g ð1Þ
where KI

app is the apparent global dissociation constant of the enzyme-inhibitor complex, vi
is the inhibited steady-state rate, v is the uninhibited rate, [I] is the total inhibitor concentra-
tion and [E] is the total enzyme concentration. The true inhibition constants, KI

, were cor-
rected from KI

app according to the Eq 2 for competitive inhibitors:
KI ¼
KI app
1þ
½S
KM
ð2Þ
Slow-binding kinetics. The decrease in the rate of product formation during the first
minutes after mixing the enzyme with the inhibitor and substrate (5 μM) was studied for
increasing inhibitor concentrations. Progress curves were analyzed using the Eq 3 [70] that
describes the slow establishment of equilibrium between the enzyme and the inhibitor accord-
ing to:
P ¼ vit þ
ðv0   viÞð1   e  kobstÞ
kobs
ð3Þ
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where P is the concentration of AMC produced by hydrolysis of the substrate, vo is the initial
rate, vi is the rate once the enzyme-inhibitor equilibrium was reached, and kobs represents the
apparent first order rate constant. Computer fitting of progress curves estimated values for vo,
vi and kobs.
For Kunitz inhibitors that bind to the enzyme rapidly and reversibly forming an initial
“loose” complex EI that isomerizes slowly to the final complex EI, the reaction mechanism
can be represented by Eq 4:
Eþ I⇌EI⇌EI ð4Þ
In this mechanism, the value of the apparent rate constant (kobs) is related to the kinetic
constants of the second step, k2 and k-2, and to the equilibrium dissociation constant of the ini-
tial loose complex KI (KI = k-1/k1), by Eq 5 [24]:
kobs ¼ k  2 þ
k2½I
½I þ KIð1þ ½S=KMÞ
ð5Þ
In the case of EgKU-3 that was found to follow the mechanism represented in Eq 4, the con-
stants k2 and KI were determined from plots of kobs versus [I], by computer fitting to Eq 5.
Because k-2 was too small to be accurately estimated from these plots, it was determined with
Eq 6 [23] using data from situations where the ratio vi/vo was higher than 0.05:
k  2 ¼ kobs
vi
v0
ð6Þ
The values of k-2, k2 and KI thus determined allowed to corroborate the inhibition constant
KI

, according to Eq 7:
KI ¼ KI
k  2
k2 þ k  2
ð7Þ
Data analysis. Computer fitting to non-linear equations was performed using the soft-
ware Origin version 8 (OriginLab).
Patch-clamp experiments with EgKU-1 and EgKU-4 on DRG neurons
The effect of EgKU-1 and EgKU-4 on voltage-gated (Na+ and K+) and ASIC currents was stud-
ied using the whole cell patch-clamp technique in primary cultured rat DRG neurons. The
effect of EgKU-3 and EgKU-8 on voltage-gated K+ and ASIC currents was similarly analyzed.
α-DTX (kindly donated by Dr. Carlos Cerveñansky from the Unidad de Bioquı´mica y Proteo´-
mica Analı´ticas, Institut Pasteur de Montevideo/Instituto de Investigaciones Biolo´gicas Cle-
mente Estable, Montevideo, Uruguay) and Bovine Serum Albumin (Sigma Chemicals) were
used as positive and negative controls, respectively.
Ethics statement. The study was performed in strict accordance with the Guiding Princi-
ples from the Committee on Guide for the Care and Use of Laboratory Animals of the Na-
tional Research Council of the National Academies of the United States of America and with
the regulations of the General Law of Health and of Research in Health Matters of the Ministry
of Health of Mexico and Technical Specifications for production, use and Care of laboratory
animals (NOM-062-ZOO-1999). The animal protocol was reviewed and approved by the Insti-
tutional Animal Care and Use Committee (IACUC) of the Vice-rectory of Research and Post-
graduate Studies of the Autonomous University of Puebla (BUAP/VIEP 2014–236, BUAP/
VIEP 2015–273 and BUAP/VIEP 2016–265). All efforts were made to minimize animal
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suffering and to reduce the number of animals used. The animals were provided by the
“Claude Bernard” animal facility of the Autonomous University of Puebla.
Cell culture. The DRG neurons were isolated from the vertebral column of Wistar rats at
postnatal ages P5 to P9 without sex distinction, and cultured according to the procedure
described by Salceda and coworkers [71]. In brief, the neurons were incubated (30 min at
37˚C) in Leibovitz L15 medium (Invitrogen, USA) containing 1.25 mg/ml trypsin and 1.25
mg/ml collagenase (both from Sigma-Aldrich). After the enzymatic treatment, the ganglia
were washed 3 times with sterile L15. Cells were mechanically dissociated and plated on
12-mm x 10-mm glass coverslips (Corning, USA), pretreated with poly-D-lysine (Sigma-
Aldrich), which were placed onto 35-mm culture dishes (Corning). The isolated cells were
allowed to settle and adhere to the coverslips during 4 to 8 h in a humid atmosphere (95% air
and 5% CO2, at 37˚C) using a CO2 water-jacketed incubator (Nuaire, USA). The plating
medium was L15 supplemented with 15.7 mM NaHCO3 (Merck, Mexico), 10% fetal bovine
serum, 2.5 μg/ml fungizone (both from Invitrogen), 100 U/mL penicillin (Lakeside, Mexico),
and 15.8 mM HEPES (Sigma-Aldrich).
Electrophysiological recording. A coverslip with attached cells was transferred to a 500 μl
perfusion chamber mounted on the stage of an inverted phase-contrast microscope (TMS,
Nikon Co, Japan). Cells were bath-perfused with extracellular solution by means of a peristaltic
pump (Masterflex, L/S Easy-Load II; Cole Parmer, USA). Current recording was carried out at
room temperature (23–25˚C) using an Axopatch 1D amplifier (Molecular Devices, USA). The
cells selected for recording were refringent, they were not adhered to other cells, showed no
neurite outgrowth, and had a round soma. Command-pulse generation and data sampling were
controlled with the pClamp 9.2 software (Molecular Devices) using a 16-bit data-acquisition
system (Digidata 1320, Molecular Devices). Signals were low-pass filtered at 5 kHz and digitized
at 10 or 20 kHz, depending on the experiment. Patch pipettes were pulled from borosilicate
glass capillaries (TW120-3; WPI, USA) using a Flaming-Brown electrode puller (P-80/-PC; Sut-
ter Instruments, USA). They typically had a resistance of 1 to 3 MO when filled with intracellu-
lar solution. The series resistance was electronically compensated for by 80%. Seal and series
resistance were continuously monitored to guarantee stable recording conditions.
Experimental protocols and data analysis. To study their effects on voltage-gated K+ and
Na+ currents, the EgKUs were ejected under pressure using a microinjector (Baby Bee, USA)
from a micropipette positioned in the vicinity of the cell under recording. For the recording
of total currents, the cells were perfused with an extracellular solution containing (mM):
140 NaCl, 5.4 KCl, 1.8 CaCl2, 1.2 MgCl2, 10 HEPES, adjusted to pH 7.4 with NaOH. For the
recording of ASIC currents, the same solution was employed but HEPES was substituted by
MES (10 mM) and pH was adjusted to 6.1. For these experiments, the patch pipettes were filled
with an intracellular solution containing (mM): 10 NaCl, 125 KCl, 0.1 CaCl2, 10 EGTA, 5
HEPES, 1 NaGTP, 2 MgATP, adjusted to pH 7.2 with KOH.
Potassium transmembrane currents were elicited by a single-step voltage protocol applying
a 120 ms pre-pulse to -100 mV before the 0 mV (800 ms) test pulse with an interval between
sweeps of 8 s (holding potencial, Vh = -60 mV). For current-voltage (I/V) analyses, the total
potassium current was obtained from a Vh of -45 mV through a series of voltage steps (from
-65 to 55 mV, every 8 s) preceded by a conditioning step to -120 mV (200 ms). To record the
sustained component of the current (IKDR), the conditioning step was set to -45 mV to inacti-
vate the transient component of the current (IKA). Then IKA was calculated by a trace by trace
subtraction between the aforementioned protocols. For this group of experiments, the extra-
cellular solution contained (mM): 10 KCl, 1.8 CaCl2, 1.2 MgCl2, 0.3 CdCl2, 130 choline chlo-
ride, 10 HEPES, adjusted to pH 7.4; and the intracellular solution (mM): 50 KCl, 60 choline
chloride, 0.1 CaCl2, 40 KF, 10 EGTA, 5 HEPES, adjusted to pH 7.2.
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The EgKUs were always co-applied with the single-step voltage protocol. I/V analyses were
carried out after the effect had stabilized. Two parameters were used to evaluate the effect: the
maximum amplitude of the current and the amplitude of the current in the last 10 ms of the
test pulse.
Sodium currents were evoked by a 40 ms depolarization step to a membrane potential of
-10 mV from a Vh of -100 mV, with an interval between sweeps of 8 s. Three parameters were
used to evaluate the effect of the EgKUs: the maximum amplitude of the current (INamax), the
time constant of the current inactivation (τh), as derived from an exponential fit, and the ratio
between the current amplitude at the end of the voltage pulse and INamax (INaend/INamax),
which gives an estimate of the probability for the channels not being inactivated at the end of
the voltage pulse. Cells were bath-perfused with an extracellular solution containing (mM): 20
NaCl, 70 choline chloride, 1.8 CaCl2, 1 MgCl2, 10 HEPES, 45 tetraethylammonium chloride,
10 4-aminopyridine adjusted to pH 7.4. Pipettes were filled with the following intracellular
solution (mM): 10 NaCl, 30 CsCl, 100 CsF, 5 HEPES, 8 EGTA, 10 tetraethylammonium chlo-
ride, adjusted to pH 7.2.
The ASIC currents were generated by a fast (about 100 ms) pH change from 7.4 to 6.1, by
shifting one of the three outlets of a fast change perfusion system (SF-77B, Warner Inst, USA)
while keeping the cell at a Vh of -60 mV (the extracellular solution of pH 6.1 contained MES,
pK = 6.15, instead of HEPES, pK = 7.55). The pH was kept at 6.1 during 5 s. The time between
pH changes was 1 min to guarantee that the ASIC current was completely recovered from
desensitization. The transient receptor potential vanilloid 1 (TRPV1) antagonist capsazepine
(10 μM) (Sigma-Aldrich) was added to the extracellular solution (pH 6.1) to prevent activation
of the TRPV1 receptor present in DRG neurons. The ASIC currents were characterized by the
maximum peak amplitude (Ipeak), the desensitization time-constant (τdes, determined by fit-
ting the decay phase of the current with a single exponential function), and the amplitude at
the steady state (Iend) measured at the last 100 ms of the acid pulse. The EgKUs were applied
20 s before and during the acid pulse (sustained application). At least two control responses
were recorded before any experimental manipulation. The pH of the perfusion solution was
checked not to be affected by addition of the inhibitors.
Concentration-response data were fitted with the function Y = min + (max-min)/[1+(x/
EC50)
H], where Y is the effect of the inhibitor, x is the concentration, max and min are the
maximum and minimum effects, EC50 is the concentration at which 50% of the effect is
obtained and H is the Hill coefficient. Experimental data are presented as the mean ± standard
error. To define the statistical significance, a paired Student’s t-test was used and P 0.05 was
considered as significant, when comparing the effects in the presence and absence of inhibitor.
Analysis of EgKUs in parasite secretions
Fresh hydatid fluid was recovered under aseptic conditions from individual fertile cysts of the
G1 genotype (E. granulosus sensu stricto), present in the lungs of naturally infected bovines in
Uruguay, and kept at -70˚C. Cysts were collected during the routine work of local abattoirs in
Montevideo. Cyst fluid was analyzed by MALDI-TOF MS using a Voyager DE-PRO spectrom-
eter (Applied Biosystems). The sample was concentrated by vacuum drying, desalted using
C18 reverse phase micro-columns (OMIX Pipette tips, Varian) and eluted with matrix solution
(α-cyano-4-hydroxycinnamic acid in 0.2% trifluoroacetic acid in 50% v/v acetonitrile-H2O)
directly on the MALDI sample plate.
An aliquot of adult worm in vitro secretions was kindly provided by MSc Noelia Morel; the
culture was carried out in our department in the context of a project to develop a copro-ELISA
kit for canine echinococcosis [72]. Worm secretions were prepared essentially as described by
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Casaravilla and coworkers [73]. In brief, adult worms were recovered from the intestine of
dogs experimentally infected with E. granulosus (euthanized 30 days post-infection), washed
with sterile phosphate-buffered saline (PBS) and cultured in RPMI containing 105 UI/L peni-
cillin, 100 mg/L streptomycin and 250 μg/L amphotericin B, at 37˚C in 5% CO2.The superna-
tant was collected every 8 h for two days and kept at -70˚C. An aliquot was clarified by
centrifugation at 10,000 g and analyzed as described for cyst fluid.
EgKU-3 and EgKU-8 were affinity purified from hydatid fluid and worm secretions using
chymotrypsin A agarose (Sigma-Aldrich, USA) and analyzed by MALDI-TOF MS (4800
MALDI TOF/TOF analyzer, ABi Sciex) to confirm their presence in the parasite secretions.
The resin containing agarose-bound bovine chymotrypsin A (1.5 mg) was rehydrated and
equilibrated with 10 mM Tris-HCl buffer pH 7.5. Cyst fluid (1 ml) was incubated in batch with
the resin during 10 min at 20˚C; the resin was then washed 3 times with 10 mM Tris-HCl pH
7.5, and the EgKUs were eluted by incubation during 10 min with 25 μl of 0.2% trifluoroacetic
acid. After centrifugation, 1 μl of the eluate was applied directly on the MALDI sample plate
with 1 μl of the matrix solution (α-cyano-4-hydroxycinnamic acid in 0.1% trifluoroacetic acid
in 60% v/v acetonitrile-H2O). Mass spectra were acquired in positive ion linear mode and
externally calibrated using protein standards (Applied Biosystems). The EgKUs were purified
from adult worm secretions with the same protocol, using 3 ml of the sample previously con-
centrated by vacuum drying.
EgKU-3 and EgKU-8 purified from cyst fluid were characterized by peptide mass finger-
printing; the eluate was reduced and alkylated with iodoacetamide prior to treatment with
trypsin (Sequencing-grade, Promega). The sequence of selected peptides was confirmed by
collision-induced dissociation MS/MS experiments, as previously described [3].
Structural modeling
The full-length mature sequences of EgKU-1, EgKU-3, EgKU-4 and EgKU-8 were used to com-
pute structural models using the i-Tasser server [74]. The C-scores for all models were higher
than 0 (EgKU-1 = 0.93; EgKU-3 = 1.23; EgKU-4 = 0.05; EgKU-8 = 1.13). Typical C-scores
range from [–2, 5], with higher scores meaning more reliable models. α-DTX did not stand
amongst the top 10 threading templates used by i-Tasser, which allowed direct comparisons
with no circularities in the analyses. Electrostatic properties were calculated at pH 7.4 with the
Adaptive Poisson Boltzmann Solver [75] for the best i-Tasser models as well as for the crystal
structure of α-DTX (PDB access code 1DTX). Next, per-residue solvent-accessibility was com-
puted with the “areaimol” program from the CCP4 suite [76]. Basic, acidic and aromatic resi-
dues with solvent accessibilities above 40 Å2 were displayed in van der Waals representation
onto a cartoon backbone of the model, using VMD [77]. Electrostatic molecular surface repre-
sentations were produced and rendered with PyMol (http://pymol.sourceforge.net).
Phylogenetic analysis
The Kunitz domains from EgKU-1-EgKU-8 as well as from eight additional monodomain
Kunitz proteins identified in the E. granulosus genome sequences (encoded by EgrG_001136500,
EgrG_001136600, EgrG_001136800, EgrG_001137000, EgrG_001137200, EgrG_1137300 and
EgrG_1137400 from the genome produced at the Wellcome Trust Sanger Centre [5]; and the
protein EGR_07242, from the genome produced at the Chinese National Human Genome Cen-
ter [35]) were multiply aligned with Mafft [78] (L-insi option). Eleven close paralogs (some of
which are putative orthologs) of the E. granulosus monodomain Kunitz proteins identified within
genomic and transcriptomic data from the T. solium genome project [5] (encoded by genes
TsM_000321400, TsM_000410200, TsM_000513000, TsM_000576900, TsM_000647700,
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TsM_000724900, TsM_001022000, TsM_001027800, TsM_001085400, TsM_001162600
retrieved from GeneDB—http://www.genedb.org/Homepage/Tsolium; and the EST EL746785
retrieved as TSE0004567 from PartiGeneDB—http://www.compsysbio.org/partigene/) were
added to this set. A group of five functionally annotated sequences from other Lophotrochozoa
was also included: FhKTM (UniProt Q9TXD3; [42]) and FhKT1 [43], from F. hepatica; SjKI-1
(Sjp_0020270) from S. japonicum [37]; SmKI-1 (Smp_147730) from S. mansoni [38] and Conku-
nitzin-S1 (UniProt P0C1X2) from the mollusk Conus striatus [14]. The alignment of these 32
proteins was used as input for MrBayes [79] for a Bayesian phylogenetic reconstruction using the
Poisson substitution model in a run of 1,000,000 generations, discarding the first 100,000 for
summarizing results (mcmc ngen = 1000000; sump burnin = 100000; sumt burnin = 100000).
The short sequence length of the Kunitz domain prevents robust and reliable identification of
many branching events. Furthermore, saturation events are guaranteed to occur and may be dif-
ficult to pinpoint. The tree is one of the best we can get with current methods. In fact, maximum
likelihood reconstruction with 1000 bootstraps provided poorer support for branching events.
The final dendrogram was visualized and rendered in FigTree (http://tree.bio.ed.ac.uk/software/
figtree). It should be noted that the proteins encoded by EgrG_001136500, EgrG_001136600,
EgrG_001137000, EgrG_001137200, and EgrG_001137400 [5] correspond to EGR_08721,
EGR_08720, EGR_08716, EGR_9006, and EGR_9007 [35], respectively.
Supporting information
S1 Dataset. Peptide mass fingerprinting of chymotrypsin affinity purified proteins from
hydatid cyst fluid. (A) MALDI-TOF mass spectrum of peptides generated by tryptic digestion
of cyst fluid proteins recovered after an affinity purification step using chymotrypsin A. The
signals that can be assigned to peptides derived from EgKU-8 or EgKU-3 are indicated (refer
to Fig 10C). The signal of m/z 1074.54 corresponds to EgKU-8 sequence LPLDPGFcR (theo-
retical MH+ 1074.53); the signal of m/z 1164.52 to EgKU-3 sequence EQcELLcGR (theoretical
MH+ 1164.51); and the signal of m/z 1491.63 to EgKU-8 sequence WGFHQESGEcVR (theo-
retical MH+ 1491.64); c indicates carbamidomethyl Cys. (B) MS/MS analysis of tryptic pep-
tides from EgKU-3 and EgKU-8. The list of theoretical m/z values of fragment ions is shown
for each sequence, and the ions detected in the MS/MS spectra are highlighted in bold. a and b
ions correspond to N-terminal fragments, and y ions to C-terminal fragments, according to
the accepted nomenclature [80,81].
(PDF)
S1 Fig. Studies with EgKU-1 and EgKU-4 on isolated Na+ currents from DRG neurons.
Representative traces showing that the sustained (25 s) perfusion of 100 nM recombinant
EgKU-1 (A) or EgKU-4 (C) does not block voltage-activated sodium channels (Nav). (B) and
(D) are the current-voltage relationships of the peak Na+ current from the traces in (A) and
(C), respectively. The black traces correspond to control conditions and the gray ones after
EgKU perfusion.
(TIF)
S2 Fig. MALDI-TOF MS analysis of recombinant EgKUs: results for EgKU-3. Mass spec-
trometry analyses of free thiols and disulphide bonds were carried out as described in Calvete
[64]. Three samples were examined for each purified recombinant EgKU: i) untreated (A); ii)
denatured with guanidinium hydrochloride and treated with iodoacetamide (IA), to assess the
presence of free thiols (B); iii) denatured with guanidinium hydrochloride, reduced with DTT
and treated with IA to confirm the presence of 6 Cys residues (C). Predicted MH+ values for
EgKU-3 are as follows: untreated EgKU-3 (3 Cys-Cys) = 9819 Da; reduced and alkylated
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EgKU-3 = 10167 Da.
(TIF)
S1 Table. cDNA and gene sequence data from EgKU-1-EgKU-8.
(PDF)
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